Literature DB >> 28299530

In-depth Characterization of the Homodimerization Domain of the Transcription Factor THAP1 and Dystonia-Causing Mutations Therein.

Alev Richter1, Ronja Hollstein1, Eva Hebert2, Franca Vulinovic2, Juliane Eckhold1, Alma Osmanovic1, Reinhard Depping3, Frank J Kaiser1, Katja Lohmann4.   

Abstract

Mutations in the THAP1 gene encoding the transcription factor THAP1 have been shown to cause DYT6 dystonia. THAP1 contains a highly conserved THAP zinc finger at its N-terminal region which allows specific binding to its target sequences as well as a coiled-coil domain (amino acids 139-190) towards its C-terminus postulated as a protein-protein-binding motif. While several DYT6-causing mutations within the THAP domain were shown to decrease THAP1 activity in transcriptional regulation and DNA-binding, the role of mutations within the coiled-coil domain is rather unknown. Therefore, assigning a function to this domain may enable functional testing of mutations in this region. Notably, THAP1 and other THAP proteins form homodimers; however, the responsible domain has not been elucidated in detail. We show that the region of amino acids 139-185 is involved in formation of THAP1 homodimers by using yeast-two-hybrid, GST pull-down, and cross-linking assays. Surprisingly, all nine reported DYT6-causing missense mutations within this region had no effect on dimerization of THAP1 in GST pull-down and formaldehyde cross-linking assays. In conclusion, we demonstrated that a region of 47 amino acids is involved in THAP1 homodimerization but mutations in this region seem not to impair this mechanism.

Entities:  

Keywords:  Dystonia; Homodimerization; Mutation; Transcription

Mesh:

Substances:

Year:  2017        PMID: 28299530     DOI: 10.1007/s12031-017-0904-2

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  20 in total

Review 1.  Genotype-phenotype correlations in THAP1 dystonia: molecular foundations and description of new cases.

Authors:  Mark S LeDoux; Jianfeng Xiao; Monika Rudzińska; Robert W Bastian; Zbigniew K Wszolek; Jay A Van Gerpen; Andreas Puschmann; Dragana Momčilović; Satya R Vemula; Yu Zhao
Journal:  Parkinsonism Relat Disord       Date:  2012-02-28       Impact factor: 4.891

2.  Truncating mutations in THAP1 define the nuclear localization signal.

Authors:  Alma Osmanovic; Andreas Dendorfer; Alev Erogullari; Nils Uflacker; Diana Braunholz; Aleksandar Rakovic; Gudrun Vierke; Conchi Gil-Rodríguez; Alexander Münchau; Melanie Albrecht; Norbert Brüggemann; Gabriele Gillessen-Kaesbach; Christine Klein; Katja Lohmann; Frank J Kaiser
Journal:  Mov Disord       Date:  2011-04-14       Impact factor: 10.338

3.  Screening for rare sequence variants in the THAP1 gene in a primary dystonia cohort.

Authors:  Jeremy R B Newman; Alexander C Lehn; Richard S Boyle; Peter A Silburn; George D Mellick
Journal:  Mov Disord       Date:  2013-05-06       Impact factor: 10.338

4.  Performance of mutation pathogenicity prediction methods on missense variants.

Authors:  Janita Thusberg; Ayodeji Olatubosun; Mauno Vihinen
Journal:  Hum Mutat       Date:  2011-02-22       Impact factor: 4.878

5.  Clinical and genetic evaluation of DYT1 and DYT6 primary dystonia in China.

Authors:  F B Cheng; X H Wan; J C Feng; L Wang; Y M Yang; L Y Cui
Journal:  Eur J Neurol       Date:  2010-09-06       Impact factor: 6.089

6.  Prevalence of THAP1 sequence variants in German patients with primary dystonia.

Authors:  Anne S Söhn; Nicola Glöckle; Andrea Duarte Doetzer; Günther Deuschl; Ute Felbor; Helge R Topka; Ludger Schöls; Olaf Riess; Peter Bauer; Ulrich Müller; Kathrin Grundmann
Journal:  Mov Disord       Date:  2010-09-15       Impact factor: 10.338

7.  Novel THAP1 sequence variants in primary dystonia.

Authors:  J Xiao; Y Zhao; R W Bastian; J S Perlmutter; B A Racette; S D Tabbal; M Karimi; R C Paniello; Z K Wszolek; R J Uitti; J A Van Gerpen; D K Simon; D Tarsy; P Hedera; D D Truong; K P Frei; S Dev Batish; A Blitzer; R F Pfeiffer; S Gong; M S LeDoux
Journal:  Neurology       Date:  2010-01-19       Impact factor: 9.910

8.  Ronin is essential for embryogenesis and the pluripotency of mouse embryonic stem cells.

Authors:  Marion Dejosez; Joshua S Krumenacker; Laura Jo Zitur; Marco Passeri; Li-Fang Chu; Zhou Songyang; James A Thomson; Thomas P Zwaka
Journal:  Cell       Date:  2008-06-27       Impact factor: 41.582

9.  Mutations in THAP1 (DYT6) in early-onset dystonia: a genetic screening study.

Authors:  Susan B Bressman; Deborah Raymond; Tania Fuchs; Gary A Heiman; Laurie J Ozelius; Rachel Saunders-Pullman
Journal:  Lancet Neurol       Date:  2009-04-01       Impact factor: 44.182

10.  Chemotrap-1: an engineered soluble receptor that blocks chemokine-induced migration of metastatic cancer cells in vivo.

Authors:  Silvia Lanati; Darryl B Dunn; Myriam Roussigné; Maxine S Emmett; Virginie Carriere; Denis Jullien; Jessica Budge; Justin Fryer; Monique Erard; Françoise Cailler; Jean-Phillippe Girard; David O Bates
Journal:  Cancer Res       Date:  2010-08-24       Impact factor: 12.701

View more
  5 in total

1.  A pathogenic DYT-THAP1 dystonia mutation causes hypomyelination and loss of YY1 binding.

Authors:  Dhananjay Yellajoshyula; Abigail E Rogers; Audrey J Kim; Sumin Kim; Samuel S Pappas; William T Dauer
Journal:  Hum Mol Genet       Date:  2022-03-31       Impact factor: 5.121

2.  Classification of the human THAP protein family identifies an evolutionarily conserved coiled coil region.

Authors:  Hiral M Sanghavi; Sairam S Mallajosyula; Sharmistha Majumdar
Journal:  BMC Struct Biol       Date:  2019-03-05

3.  THAP11 Functions as a Tumor Suppressor in Gastric Cancer through Regulating c-Myc Signaling Pathways.

Authors:  Jing Zhang; Huahua Zhang; Haiyan Shi; Fenghui Wang; Juan Du; Yu Wang; Yameng Wei; Wanjuan Xue; Dan Li; Yun Feng; Jing Yan; Yi Gao; Jia Li; Jiming Han
Journal:  Biomed Res Int       Date:  2020-08-27       Impact factor: 3.411

4.  DREAM represses distinct targets by cooperating with different THAP domain proteins.

Authors:  Csenge Gal; Francesco Nicola Carelli; Alex Appert; Chiara Cerrato; Ni Huang; Yan Dong; Jane Murphy; Andrea Frapporti; Julie Ahringer
Journal:  Cell Rep       Date:  2021-10-19       Impact factor: 9.423

5.  THAP11F80L cobalamin disorder-associated mutation reveals normal and pathogenic THAP11 functions in gene expression and cell proliferation.

Authors:  Harmonie Dehaene; Viviane Praz; Philippe Lhôte; Maykel Lopes; Winship Herr
Journal:  PLoS One       Date:  2020-01-06       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.